This is the classic website, which will be retired eventually. Please visit the modernized ClinicalTrials.gov instead.
Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT05232916
Brief Title: Phase 3 Study to Evaluate the Efficacy and Safety of HER2/Neu Peptide GLSI-100 (GP2 + GM-CSF) in HER2/Neu Positive Subjects (FLAMINGO-01)

First Submitted : January 31, 2022
First Submitted that Met QC Criteria : January 31, 2022
First Posted : February 10, 2022

Last Update Submitted that Met QC Criteria : January 12, 2024
Last Update Posted : January 16, 2024